Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes

Rivas, M. A., Durmaz, C., Kloetgen, A., Chin, C. R., Chen, Z., Bhinder, B., Koren, A., Viny, A. D., Scharer, C. D., Boss, J. M., Elemento, O., Mason, C. E., & Melnick, A. M. (2021). Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.688493
Authors:
Martin A Rivas
Ceyda Durmaz
Andreas Kloetgen
Cristopher R Chin
Zhengming Chen
Bhavneet Bhinder
Amnon Koren
Aaron D Viny
Christopher D Scharer
Jeremy M Boss
Olivier Elemento
Christopher E Mason
Ari M Melnick
Affiliated Authors:
Aaron D Viny
Columbia Affiliation:
Subjects:
B-Lymphocytes (MeSH)
Biomarkers, Tumor (MeSH)
Cell Cycle Proteins (MeSH)
Chondroitin Sulfate Proteoglycans (MeSH)
Chromosomal Proteins, Non-Histone (MeSH)
Gene Dosage (MeSH)
Germinal Center (MeSH)
Haploinsufficiency (MeSH)
Lymphoma, Large B-Cell, Diffuse (MeSH)
Plasma Cells (MeSH)
Author Keywords:
b-cell
gcb-subtype dlbcl
hi-c
tet2 gene
chromosomal architecture
cohesin
lymphoma
elink
Publication Type:
Article
Unique ID:
10.3389/fimmu.2021.688493
PMID:
34621263
DOI:
10.3389/fimmu.2021.688493
Journal:
Frontiers in Immunology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: